Clinical trial
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are…
NCT00077324 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00077324 |
|---|---|
| Title | Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions |
| Official title | Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Lung Cancer |
| Intervention type | Genetic, Other, Procedure |
| Interventions | proteomic profiling, surface-enhanced laser desorption/ionization-time of flight mass spectrometry, biopsy, surgery |
| Enrollment | 1,000 |
| Start date | Feb 1, 2004 |
| Primary completion | Nov 1, 2011 |
| Completion | Nov 1, 2011 |
| First posted | Feb 12, 2004 |
| Last update posted | Jul 6, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: